![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CDX1 |
Gene summary for CDX1 |
![]() |
Gene information | Species | Human | Gene symbol | CDX1 | Gene ID | 1044 |
Gene name | caudal type homeobox 1 | |
Gene Alias | CDX1 | |
Cytomap | 5q32 | |
Gene Type | protein-coding | GO ID | GO:0001501 | UniProtAcc | P47902 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1044 | CDX1 | HTA11_2487_2000001011 | Human | Colorectum | SER | 5.97e-13 | 5.47e-01 | -0.1808 |
1044 | CDX1 | HTA11_2951_2000001011 | Human | Colorectum | AD | 3.41e-03 | 3.33e-01 | 0.0216 |
1044 | CDX1 | HTA11_1938_2000001011 | Human | Colorectum | AD | 2.96e-05 | 4.59e-01 | -0.0811 |
1044 | CDX1 | HTA11_78_2000001011 | Human | Colorectum | AD | 1.89e-07 | 4.48e-01 | -0.1088 |
1044 | CDX1 | HTA11_347_2000001011 | Human | Colorectum | AD | 4.91e-27 | 6.87e-01 | -0.1954 |
1044 | CDX1 | HTA11_411_2000001011 | Human | Colorectum | SER | 1.07e-11 | 1.07e+00 | -0.2602 |
1044 | CDX1 | HTA11_2112_2000001011 | Human | Colorectum | SER | 1.88e-09 | 1.05e+00 | -0.2196 |
1044 | CDX1 | HTA11_3361_2000001011 | Human | Colorectum | AD | 7.13e-14 | 6.35e-01 | -0.1207 |
1044 | CDX1 | HTA11_83_2000001011 | Human | Colorectum | SER | 4.74e-06 | 5.71e-01 | -0.1526 |
1044 | CDX1 | HTA11_696_2000001011 | Human | Colorectum | AD | 2.07e-34 | 7.98e-01 | -0.1464 |
1044 | CDX1 | HTA11_866_2000001011 | Human | Colorectum | AD | 5.89e-09 | 4.05e-01 | -0.1001 |
1044 | CDX1 | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.41e-18 | 7.63e-01 | -0.059 |
1044 | CDX1 | HTA11_2992_2000001011 | Human | Colorectum | SER | 1.15e-09 | 8.89e-01 | -0.1706 |
1044 | CDX1 | HTA11_5212_2000001011 | Human | Colorectum | AD | 1.50e-12 | 7.25e-01 | -0.2061 |
1044 | CDX1 | HTA11_5216_2000001011 | Human | Colorectum | SER | 2.35e-03 | 6.16e-01 | -0.1462 |
1044 | CDX1 | HTA11_546_2000001011 | Human | Colorectum | AD | 7.99e-11 | 6.58e-01 | -0.0842 |
1044 | CDX1 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.50e-05 | 3.64e-01 | 0.096 |
1044 | CDX1 | HTA11_8622_2000001021 | Human | Colorectum | SER | 8.40e-03 | 3.95e-01 | 0.0528 |
1044 | CDX1 | HTA11_7663_2000001011 | Human | Colorectum | SER | 2.03e-12 | 6.87e-01 | 0.0131 |
1044 | CDX1 | HTA11_10711_2000001011 | Human | Colorectum | AD | 3.53e-05 | 3.63e-01 | 0.0338 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Cervix | N_HPV | ![]() |
Endometrium | AEH | ![]() |
Endometrium | EEC | ![]() |
Prostate | BPH | ![]() |
Prostate | Tumor | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 2 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CDX1 | SNV | Missense_Mutation | rs771897143 | c.496C>T | p.Arg166Cys | p.R166C | P47902 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-AJ-A3OL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | PD |
CDX1 | SNV | Missense_Mutation | novel | c.550N>G | p.Lys184Glu | p.K184E | P47902 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-AJ-A5DW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CDX1 | SNV | Missense_Mutation | rs140956520 | c.547N>T | p.Arg183Trp | p.R183W | P47902 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AX-A0J1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CDX1 | SNV | Missense_Mutation | rs143202475 | c.586N>T | p.Arg196Trp | p.R196W | P47902 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
CDX1 | SNV | Missense_Mutation | novel | c.736A>G | p.Ser246Gly | p.S246G | P47902 | protein_coding | tolerated(0.22) | benign(0) | TCGA-AX-A2HJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CDX1 | SNV | Missense_Mutation | rs758524697 | c.628C>T | p.Arg210Cys | p.R210C | P47902 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
CDX1 | SNV | Missense_Mutation | rs200074812 | c.530G>A | p.Arg177His | p.R177H | P47902 | protein_coding | deleterious(0) | possibly_damaging(0.698) | TCGA-DI-A2QU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
CDX1 | SNV | Missense_Mutation | rs777049283 | c.688N>A | p.Asp230Asn | p.D230N | P47902 | protein_coding | tolerated_low_confidence(0.72) | benign(0.015) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CDX1 | SNV | Missense_Mutation | novel | c.698N>T | p.Ala233Val | p.A233V | P47902 | protein_coding | tolerated(0.09) | benign(0.023) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
CDX1 | deletion | Frame_Shift_Del | novel | c.704delC | p.Pro235GlnfsTer25 | p.P235Qfs*25 | P47902 | protein_coding | TCGA-D1-A177-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |